Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Branded drug or biosimilar? Reasons to adopt generics in rheumatology, by Professor Jonathan Kay

    Branded drug or biosimilar? Reasons to adopt generics in rheumatology, by Professor Jonathan Kay

    FromRMD Open Podcast

    Start listeningView podcast show

    Branded drug or biosimilar? Reasons to adopt generics in rheumatology, by Professor Jonathan Kay

    FromRMD Open Podcast

    ratings:
    Length:
    5 minutes
    Released:
    Nov 6, 2017
    Format:
    Podcast episode

    Description

    Professor Jonathan Kay (Division of Rheumatology, Department of Medicine, University of Massachusetts Medical School and UMass Memorial Medical Center, Worcester, Massachusetts, USA) tells Editor-in-Chief of RMD Open Bernard Combe why he supports the switch from branded drugs to their cheaper biosimilar.
    They spoke at the EULAR conference 2017, held in Madrid, in June.
    For more information on this topic read:
    • Key design considerations on comparative clinical efficacy studies for biosimilars: adalimumab as an example - http://rmdopen.bmj.com/content/2/1/e000154
    • Biosimilars: what do patients need to consider? - http://rmdopen.bmj.com/content/1/1/e000141
    • Biosimilars in rheumatology: what the clinician should know - http://rmdopen.bmj.com/content/1/1/e000010
    • Switching from originator biological agents to biosimilars: what is the evidence and what are the issues? - http://rmdopen.bmj.com/content/3/2/e000492.
    Released:
    Nov 6, 2017
    Format:
    Podcast episode

    Titles in the series (17)

    RMD Open is an online only Open Access journal that publishes high-quality peer-reviewed original research covering the full spectrum of musculoskeletal disorders, rheumatism and connective tissue diseases, including osteoporosis, spine and rehabilitation. Clinical and epidemiological research, basic and translational medicine, interesting clinical cases, and smaller studies that add to the literature are all considered. RMD Open is co-owned by EULAR and BMJ. http://rmdopen.bmj.com/ * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.